Loading clinical trials...
Loading clinical trials...
This study is for patients with non-hodgkin's lymphoma or chronic lymphocytic leukemia, which has failed to shrink or has returned after previous treatment with chemotherapy. The purpose of this study...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Southern California
NCT00131014 · Non-Hodgkin's Lymphoma, Hodgkin's Disease, and more
NCT06846671 · CLL, Chronic Lymphocytic Leukemia
NCT07218341 · Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
NCT06548152 · Chronic Lymphocytic Leukemia
NCT05735717 · Hematologic Malignancy, Acute Leukemia, and more
USC/Norris Comprehensive Cancer Center and Hospital
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions